Fisetin for Alzheimer's Disease
(FIS-AD Trial)
SC
Overseen ByStudy Coordinator
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Sunnybrook Health Sciences Centre
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial
What You Need to Know Before You Apply
What is the purpose of this trial?
This pilot study will evaluate the safety and tolerability of the natural health product, fisetin, in older adults with mild cognitive impairment or mild Alzheimer's disease dementia.
Who Is on the Research Team?
KL
Krista Lanctôt, PhD
Principal Investigator
Sunnybrook Research Institute
Are You a Good Fit for This Trial?
Inclusion Criteria
Moca score of 11 or higher
I have mild memory problems or mild Alzheimer's disease.
My mental health medications have not changed recently.
Exclusion Criteria
Presence of any medical condition, or abnormal routine blood test, that the investigator believes would put the subject at risk or would preclude the patient from completing all aspects of the trial
Unstable medical disorders
Known hypersensitivity or allergy to fisetin
See 9 more
What Are the Treatments Tested in This Trial?
Interventions
- Fisetin
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: FisetinExperimental Treatment1 Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sunnybrook Health Sciences Centre
Lead Sponsor
Trials
693
Recruited
1,569,000+
Sunnybrook Research Institute
Collaborator
Trials
33
Recruited
216,000+
Other People Viewed
By Subject
By Trial
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.